Physitrack PLC (PTRK) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Physitrack PLC (PTRK) has a cash flow conversion efficiency ratio of 0.114x as of November 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr1.14 Million ≈ $122.73K USD) by net assets (Skr9.99 Million ≈ $1.08 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Physitrack PLC - Cash Flow Conversion Efficiency Trend (2017–2025)
This chart illustrates how Physitrack PLC's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read PTRK liabilities breakdown for a breakdown of total debt and financial obligations.
Physitrack PLC Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Physitrack PLC ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GREAT PORTLAND ESTATES PLC
LSE:GPE
|
0.002x |
|
Tae Won Mulsan
KO:001420
|
0.054x |
|
Conneqt Health Limited
AU:CQT
|
-17.200x |
|
Envoy Medical Inc.
NASDAQ:COCH
|
0.575x |
|
Tomypak Holdings Bhd
KLSE:7285
|
-0.069x |
|
INFLECTION RESOURCES LTD.
F:5VJ
|
-0.009x |
|
ICH Co Ltd
KQ:368600
|
-0.014x |
|
Raptis Group Ltd
AU:RPG
|
0.037x |
Annual Cash Flow Conversion Efficiency for Physitrack PLC (2017–2025)
The table below shows the annual cash flow conversion efficiency of Physitrack PLC from 2017 to 2025. For the full company profile with market capitalisation and key ratios, see Physitrack PLC market capitalisation.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-11-30 | Skr9.99 Million ≈ $1.08 Million |
Skr3.88 Million ≈ $417.72K |
0.388x | +138.11% |
| 2024-11-30 | Skr19.17 Million ≈ $2.06 Million |
Skr3.13 Million ≈ $336.50K |
0.163x | +57.55% |
| 2023-11-30 | Skr25.57 Million ≈ $2.75 Million |
Skr2.65 Million ≈ $284.98K |
0.104x | +59.58% |
| 2022-11-30 | Skr22.37 Million ≈ $2.41 Million |
Skr1.45 Million ≈ $156.22K |
0.065x | +181.76% |
| 2021-11-30 | Skr28.65 Million ≈ $3.08 Million |
Skr659.81K ≈ $71.01K |
0.023x | -94.12% |
| 2020-11-30 | Skr5.19 Million ≈ $558.20K |
Skr2.03 Million ≈ $218.73K |
0.392x | -19.70% |
| 2019-11-30 | Skr1.03 Million ≈ $110.46K |
Skr500.89K ≈ $53.90K |
0.488x | -17.54% |
| 2018-11-30 | Skr1.19 Million ≈ $128.31K |
Skr705.60K ≈ $75.93K |
0.592x | +45.95% |
| 2017-11-30 | Skr1.35 Million ≈ $145.78K |
Skr549.27K ≈ $59.11K |
0.405x | -- |
About Physitrack PLC
Physitrack PLC, together with its subsidiaries, provides digital healthcare solutions in the United Kingdom, Europe, North America, and internationally. It operates through two segments, Lifecare and Wellness. The company offers Physitrack, a remote therapeutic monitoring platform that provides a suite of tools for exercise program prescription, patient-reported adherence and tracking, and telehe… Read more